Clinical Trial

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-10; most recent amendment 2026-02-26.
Trial Details
NCT Number NCT07075718
Lead Sponsor Glaukos Corporation
Conditions Glaucoma
Enrollment 610 participants
Start Date 2025-06-12
Primary Completion 2028-03 (estimated)
Study Completion 2032-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-02